Lacroix, Ludovic
Institut Gustave Roussy
3 papers on CoChatORCID 0000-0003-2535-1010
Most cited papers
- Verified
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer
Coutzac, C., Jouniaux, J.-M., Paci, A., Schmidt, J., Mallardo, D., Seck, A., Asvatourian, V., Cassard, L., Saulnier, P., Lacroix, L., et al. (2020) · Nature Communications
Cancer Immunotherapy and BiomarkersGut microbiota and health
Cited by 513
- Verified
Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network
Beau-Faller, M., Prim, N., Ruppert, A.-M., Nanni-Metéllus, I., Lacave, R., Lacroix, L., Escande, F., Lizard, S., Pretet, J.-L., Rouquette, I., et al. (2014) · Annals of Oncology
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 324
- Verified
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Skoulidis, F., Araujo, H. A., Do, M. T., Qian, Y., Sun, X., Galan-Cobo, A., Le, J. T., Montesion, M., Palmer, R., Jahchan, N., et al. (2024) · Nature
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 194
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free